leadf
logo-loader
viewRemote Monitored Systems

Remote Monitored Systems sees big opportunity with P2F acquisition

Snapshot

  • RMS core business is GyroMetric, which remotely monitors rotating shafts 
  • Diversified by acquiring surveillance and risk management startup Cloudveil
  • Set to buy Pharm 2 Farm and make anti-viral face masks
drone

Quick facts: Remote Monitored Systems

Price: 0.875 GBX

LSE:RMS
Market: LSE
Market Cap: £6.77 m
Follow

What does RMS do?

Remote Monitored Systems PLC (LON:RMS), formerly known as Strat Aero, has two main investments: Gyrometric and CloudVeil.

Gyrometric provides a way remotely monitor rotating shafts such as those used in wind turbines, ships and manufacturing operations to minimise downtime.

CloudVeil is a security and risk management consultancy in teh early stages of its development.

In August, Remote Monitored also agreed to buyPharm2Farm, a hydroponics specialist that has also established a business making anti-viral facemasks, though the deal still needs to be approved by shareholders.

 

How is it doing?

in September, RMS said it expects substantial revenues to be generated by Pharm 2 Farm from the sale of anti-viral face masks.

 Trevor Brown, chief executive, said: ”Since we announced the proposed acquisition, the market for Pharm 2 Farm products, in particular for face masks, has continued to grow exponentially.

P2F is setting up a production line that will be able to produce up to 5mln standard or anti-viral face masks per month.

“The successful development of a face mask with anti-viral properties will, we believe, generate substantial revenue for the enlarged group," said Brown.

“Proof of Concept for the efficacy of the anti-viral mask is imminent and mask production is anticipated to commence in the first quarter of 2021".

Elsewhere, RMS said Cloudveil is currently negotiating with a London-based law firm over a security programme and had also bid for a testing contract for one of the UK’s largest public sector financial services institutions.

Gyrometric, meanwhile, is set to start a three-month trial at a Tarmac cement manufacturing operation now that a site has become available.

RMS added that for the half-year to June it recorded a loss of £253,000 (£381,000) on revenues of £58,000 (£18,000). Cash reserves were £360,000.

 

What the boss says: Trevor Brown, chief executive 

“The successful development of a face mask [by P2F] with anti-viral properties will, we believe, generate substantial revenue for the enlarged group," 

 

Inflexion points

  • Completion of P2F acquisition
  • P2F starts to produce anti-viral face masks
  • Trial of Gyrometric technology with Tarmac

 

 

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Remote Monitored Systems named herein, including the promotion by the Company of Remote Monitored Systems in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Market Report: FTSE gets an injection of optimism from US Remdesivir approval

FTSE 100 got a lift as a first treatment for COVID-19, remdesivir, was approved in the US. London’s leading index added 41 points to 5,826 in early dealings. Gilead Inc (NASDAQ:GILD) produces remdesivir and it is said to cut COVID-19 recovery times by five days. According to the World Health...

1 day, 11 hours ago

2 min read